The insomnia market is anticipated to grow in the forecast period owing to increasing prevalence of insomnia and growing demand for its innovative treatment, emergence of therapeutics with fewer side effects as well as stressful work and working in shifts. Moreover, rise in demand for OTC sleep aids is expected to offer significant growth opportunities in the market during the forecast period.
The report on insomnia market will help Major Players and the new entrants to understand scrutinize the market in detail. This information will encourage the Major Players to decide their business strategy and achieve proposed business aims.
Get PDF sample copy: https://www.theinsightpartners.com/sample/TIPRE00005214/
Insomnia is a condition in which a person faces difficulty while falling asleep, waking up during sleep and as well as feeling tired on waking. Insomnia is linked with other health problems like asthma, depression, arthritis or pain. The causes of insomnia can be included such as depression, stress, illness and emotional or physical discomfort.
1. Mallinckrodt
2. Eisai Co., Ltd.
3. Merck Sharp & Dohme Corp. (Merck & Co., Inc)
4. Galt Pharmaceuticals, LLC.
5. Pfizer Inc.
6. Sanofi
7. Sumitomo Dainippon Pharma Co., Ltd.
8. Takeda Pharmaceutical Company Limited
9. Teva Pharmaceutical Industries Ltd.
10. Vanda Pharmaceuticals